Cambridge Companies SPG Sets Sights On The Future Of Functional Beverages Upon Leading LifeAid’s $20 Million Series C
Citing returning traffic to retailers and gyms, as well as increasing consumer demand for functional ingredients that benefit gut health and immunity, Cambridge Companies SPG plans to further invest in the wellness beverage category.
Filipp Chebotarev, Chief Operating Officer and Partner of the West Coast-based investment firm recently stressed how beverages can be a “tricky” category to invest in. Less than 3% of beverage startups make it to $10 million in annual revenue, and less than 1% of all beverage startups make it to $20 million of annual revenue, thus investing in high-growth brands north of $20 million of annual run rate in elevated energy, mental focus, sports recovery, and probiotic categories will more likely than not generate profitable returns for CPG investors.
“Because the beverage sector is so challenging,” Chebotarev explained, “we prefer to back beverage brands that have exceeded the $20 million annual revenue threshold, but we’ve have also made investments in earlier stage brands.”
Read more – https://www.forbes.com/sites/douglasyu/2021/08/17/cambridge-companies-spg-sets-sights-on-the-future-of-functional-beverages-upon-leading-lifeaids-20-million-series-c/?sh=34ae4076364e